None listed
Conditions
Brief summary
This trial is investigating the efficacy of providing neuropsychological feedback in addressing self-reported cognitive impairment in breast cancer survivors. Who is it for? You may be eligible for this trial if you are a female over the age of 18 who has completed adjuvant chemotherapy for breast cancer within past 36 months and have self-reported cognitive dysfunction attributed to cancer and/or cancer treatment. Study details Participants will be randomly allocated to either the intervention arm or the control arm. Intervention: Participants will undertake a screening interview, online cognitive assessment and complete questionnaires related to cognitive performance and health. They will then receive feedback on their results and discuss implications with a psychologist over the phone. Control: Participants will undertake a screening interview, online cognitive assessment and complete questionnaires related to cognitive performance and health. Information from this study will be used to plan future intervention studies about the impact of feedback on perceived cognitive impairment.
Interventions
Neuropsychological assessment and feedback. Assessment = (1) telephone screening interview with research assistant (20 minutes), (2) completion of WebNeuro online cognitive assessment (40 minutes), (3) completion of self-report measures online (40 minutes). The 3 assessment components can be completed on different days if preferred by the participant. Feedback = 50 minute telephone discussion of personal results and their implications from provisional psychologist or registered psychologist, fol
Neuropsychological assessment and feedback. Assessment = (1) telephone screening interview with research assistant (20 minutes), (2) completion of WebNeuro online cognitive assessment (40 minutes), (3) completion of self-report measures online (40 minutes). The 3 assessment components can be completed on different days if preferred by the participant. Feedback = 50 minute telephone discussion of personal results and their implications from provisional psychologist or registered psychologist, followed by emailed 2 page summary of results discussed during the telephone call. Feedback is provided approximately one week after the final assessment component is completed.
Sponsors
Griffith University
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Investigator)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Women greater than or equal to 18 years, completed adjuvant chemotherapy for breast cancer within past 36 months, self-report cognitive impairment in the past 7 days on the European Organisation for Research and Treatment of Cancer Core Quality of Life Questionnaire, attribute cognitive dysfunction to cancer and/or cancer treatment, speak and read English fluently, have access to a computer with internet access and an active email account
Exclusion criteria
Ongoing cancer treatment (ongoing Herceptin or similar targeted therapies, or hormonal therapies are allowable if on stable dose for at least 2 months), history of neurological disorder, current psychiatric disorder that would interfere with study participation
Outcome results
None listed